Studies on the mechanism of action of alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazones.
D000818:Animals; D002467:Cell Nucleus / Q000201:enzymology / Q000378:metabolism; D002478:Cells, Cultured; D004254:DNA Nucleotidyltransferases / Q000378:metabolism; D004273:DNA, Neoplasm / Q000096:biosynthesis; D007501:Iron / Q000494:pharmacology; D007502:Iron Chelating Agents / Q000378:metabolism; D007546:Isoquinolines / Q000494:pharmacology*; D007700:Kinetics; D051379:Mice; D009363:Neoplasm Proteins / Q000096:biosynthesis; D009711:Nucleotides / Q000096:biosynthesis; D012334:RNA, Neoplasm / Q000096:biosynthesis; D012510:Sarcoma 180 / Q000201:enzymology / Q000378:metabolism; D013329:Structure-Activity Relationship; D013882:Thiosemicarbazones / Q000494:pharmacology*; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D004273:DNA, Neoplasm; D007502:Iron Chelating Agents; D007546:Isoquinolines; D009363:Neoplasm Proteins; D009711:Nucleotides; D012334:RNA, Neoplasm; D013882:Thiosemicarbazones; D014316:Tritium; D007501:Iron; D004254:DNA Nucleotidyltransferases; D013936:Thymidine